Substance / Medication

Pirenzepine

Overview

Active Ingredient
pirenzepine
RxNorm CUI
8352

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia.
Suzuki Takahiro, Higuchi Tomohiro, Kagami Takuma et al. · Eur J Clin Pharmacol · 2021
PMID: 34059932RCT
Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade.
Pedretti Roberto F E, Prete Giovanna, Foreman Robert D et al. · J Cardiovasc Pharmacol · 2003
PMID: 12717096Observational
Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain.
Piggott Margaret, Owens Jonathan, O'Brien John et al. · J Chem Neuroanat · 2002
PMID: 12297267Observational
Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach.
Tari A, Kuruhara Y, Yonei Y et al. · J Gastroenterol · 2001
PMID: 11428583Observational
Contribution of the serotonergic system to myopia and the therapeutic effects of atropine and pirenzepine.
Thomson Kate, Karouta Cindy, Ashby Regan · Biomed Pharmacother · 2026
PMID: 41496334Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pirenzepine (substance)
SNOMED CT
398669004
UMLS CUI
C0031978
RxNorm CUI
8352

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.